School of Pharmacy
Msc Program
School of Pharmacy
University of Waterloo
MSc Program Curriculum
May 2010
Page 2 of 16
May 2010
School of Pharmacy
Msc Program
May 2010
1. INTRODUCTION
1.1. Brief listing of program and degree designations
Application for a Master of Science (MSc) and Doctor of Philosophy (PhD)
Program in Pharmacy at the University of Waterloo School of Pharmacy
The School of Pharmacy at the University of Waterloo (UW) is the first new
pharmacy school in Canada in 21 years and the first in Ontario since 1953. The
School is committed to expanding the frontiers of discovery to improve human health
and well-being. Key to realizing this goal is the establishment of a rigorous graduate
program of innovative, interdisciplinary and collaborative research in all aspects of
pharmacy.
1.2. Objectives of the programs and evidence that these objectives are being met
Master of Science Program: The objective of the MSc in Pharmacy is to prepare
students for further academic study or for careers in the pharmaceutical industry or
health professions, including those in hospitals, other healthcare facilities and
government. There is a recognized shortage of high-quality personnel in the
pharmaceutical industry with master’s level of training who can answer questions
related to physical pharmacy, dosage form design and manufacture,
pharmacokinetics, pharmaceutical engineering, and developing disciplines such as
pharmaceutical nanotechnology. There is also a shortage of pharmacists with clinical
pharmacy and pharmacy practice skills who can evaluate the impact of expanding
scopes of practice and drugs on disease state management programs with respect
to patient or population outcomes and economics.
Graduates of the MSc in Pharmacy will have demonstrated the ability to (1) identify
specific research questions and pose hypotheses; (2) design a realistic research
program to answer these questions or test hypotheses; and (3) collect, manage,
analyze and present data in a scientifically appropriate fashion. The MSc degree will
be awarded to those candidates who have successfully completed requisite courses,
participated in a departmental seminar program, and prepared and defended a thesis
embodying the results of an approved research project. Regular meetings with the
candidate’s Advisory Committee will ensure that these aims are met and that
timelines to completion are adhered to. Specific program details are in Section 2.
1.3. Fields in the programs
The School of Pharmacy is recruiting highly qualified faculty in the broad areas of
pharmaceutical sciences and professional practice. Faculty recruitments are being
sought at all levels of career development (Full, Associate and Assistant Professor)
to provide mentorship and experience at all levels of scholarship (undergraduate,
MSc, PhD and postdoctoral studies).
While the recruitment of full-time, part-time, and clinical adjunct faculty is an ongoing
process, currently the School of Pharmacy has nine full-time tenured and tenuretrack faculty and 12 part-time clinical adjunct faculty, drawn from both
Page 3 of 16
School of Pharmacy
Msc Program
May 2010
pharmaceutical sciences and pharmacy practice (these 12 part-time faculty are three
full-time equivalents). By 2015 the School of Pharmacy expects to have 30 FTE
tenured or tenure-track faculty and clinical adjunct faculty, as well as 20 staff, many
of whom will be research assistants and associates of these faculty members.
Although they will not be supervising graduate students, School of Pharmacy staff,
research assistants and associates will assist in training, guidance and mentorship
as appropriate.
MSc in Pharmacy is currently comprised of the following fields:
Field 1: Pharmaceutics: Drug and Vaccine Delivery Systems and Nanomedicine
This field encompasses research activities that focus on the design, physicochemical
characterization and in vitro and in vivo testing of novel systems for drug and vaccine
delivery. Research in this field extends from the synthesis and characterization of the
building blocks, pharmaceutical excipients and other biomaterials of pharmaceutical
dosage forms to the in vitro and in vivo assessment of newly developed delivery
systems. Specific areas include liquid, semi-solid and controlled-release dosage
forms and lipid-, surfactant-, polymer-, dendrimer-, peptide-, phage- and carbon
nanotube-based soft material delivery platforms.
This field also explores nanomedicines, i.e., drugs and drug delivery and targeting
systems that function in the nanometre size range. At this scale, drug particles and
delivery systems acquire unique properties that can enhance therapeutic
effectiveness, delivery efficiency and specificity. Nanoparticles are resistant to
sedimentation, can have enhanced adhesion to biological surfaces and the ability to
nondestructively penetrate cells, providing rapid onset of therapeutic action,
improved bioavailability and targeted delivery.
Additionally, a subsection of pharmaceutics is inherently related to pharmaceutical
manufacturing and pharmaceutical engineering, which includes development of
novel methods for formulation, fabrication and manufacturing of pharmaceutical and
vaccine dosage forms and products. This latter research is also concerned with
process improvements to upscale small-scale drug formulation processes to
industrial production levels without losing effectiveness, while improving the cost and
efficiency of delivery and manufacturing.
Field 2: Drug Design: Molecular Pharmacology, Pharmacokinetics and Toxicology
This field includes the area of molecular pharmacology intended to elucidate the
molecular basis of disease and the development of novel drug targets, leading to
rational drug design and medicinal chemistry, which, in turn, take into consideration
principles from pharmacokinetics, pharmacodynamics and toxicology. Therefore, this
field also includes research into physiologically-based pharmacokinetic models and
simulation techniques to develop more accurate pharmaceutical dosing and more
optimized drug therapies.
Page 4 of 16
School of Pharmacy
Msc Program
May 2010
2. PROGRAM REGULATIONS AND COURSES
2.1.
The intellectual development and educational experience of the student
The UW School of Pharmacy strives to promote research spanning the spectrum
from fundamental science to clinical care. Our graduate program will champion this
aim through fundamental understanding and application of concepts, collaborative
discovery and innovative, leading-edge research. Our goal is to train graduates who
will be recognized for their expertise and leadership, while making significant
contributions to the global scientific, academic and healthcare communities.
All graduate students will enrol and participate in a graduate seminar (Pharm 691 for
MSc candidates, Pharm 692 for PhD candidates), the requirements of which include
presentation of at least one seminar. This mandatory course will give students an
opportunity to practice public speaking, to present research results to their
supervisors, advisors and peers, and to scientifically critique the research of others.
An encouraged but optional element in PhD studies will be a graduate-level course in
grant preparation, which will include development of a virtual research grant proposal
to the most relevant Tri-Council funding agency (or other relevant agency that offers
peer-reviewed competitive grants) and an oral presentation and defence of the
application. Students in both MSc and PhD programs will also be encouraged to take
at least one graduate-level statistics course, particularly if their previous training is
deficient in data analysis and statistical hypothesis testing.
Students will be encouraged to present their research at a major national or
international conference, providing important exposure to the larger academic and
research community. This educational experience will help provide highly trained
graduates ready for research in academia, industry or healthcare. Students will also
be encouraged to participate in UW’s Graduate Student Research Conference, an
annual event UW hosts to provide students experience in conference presentation
(see http://www.grad.uwaterloo.ca/Conference/index.asp).
An ongoing School of Pharmacy research seminar series has recently been
launched, the inaugural presentation of which was on June 5, 2009. Both nationally
and internationally recognized researchers from academia, industry and healthcare
will be invited to present their research activities and discoveries. Graduate students
will be expected to attend this seminar series regularly.
PhD candidates for whom advanced-level teaching forms part of their career goals
will be encouraged to pursue the Certificate in University Teaching offered by the
UW Centre for Teaching Excellence (CTE) (see http://cte.uwaterloo.ca/
graduate_programs/index.html). Similarly, graduate students seeking additional
training as teaching assistants will be encouraged to attend CTE’s Departmental TA
Workshops (see http://cte.uwaterloo.ca/graduate_programs/TA_workshops.html).
Students new to Canada for whom English is not the first language will be
encouraged to enrol in CTE’s International TA Training program (see
http://cte.uwaterloo.ca/graduate_programs/ITATraining.html).
All MSc and PhD students will attend a mandatory workshop on plagiarism and the
importance of academic integrity, both in their own research and in the
Page 5 of 16
School of Pharmacy
Msc Program
May 2010
undergraduate assignments they evaluate as part of their TA responsibilities. In an
effort to eliminate plagiarism UW has made “Turnitin” available to all faculty members
and instructors (see http://ist.uwaterloo.ca/cs/Turnitin/). Turnitin is an electronic
plagiarism detection service that compares the content of papers submitted via the
UW-ACE system with that of other papers and documents in its database. Where
similarities between a student's paper and existing documents are found, Turnitin
highlights those similarities in an annotated document, showing both the student’s
paper and the original source.
To help standardize teaching and grading of undergraduates, graduate students will
be given course-specific TA manuals to guide their teaching, to establish
standardized lab protocols and demonstration procedures, and to formalize grading
of reports, tests and exams.
As the School of Pharmacy will be a catalyst for research in the pharmaceutical
sciences and pharmacy practice, workshops focused on relevant areas of research
are being planned, and will occur either annually or biannually.
2.2.
Program regulations
UW’s minimum degree requirements for master’s and doctoral degrees are
stipulated in the UW Graduate Studies Academic Calendar. The graduate program
regulations noted here are based upon these guidelines.
2.2.1. Application
Only students who are graduates of approved universities and colleges are
eligible for admission to graduate studies at UW. Application for admission must
be made using UW’s online application for admission system (see
http://www.grad.uwaterloo.ca/students/prospective/admissions.asp).
A
nonrefundable application fee of $100 is required for each application submitted.
2.2.2. Admission
Admission to the MSc Program
Students applying for an MSc in Pharmacy will require a minimum 78% (B+)
average in the last two years of their four-year Honours Bachelor’s program or
equivalent. Two letters of reference from academic referees are also required.
However, a student may be admitted on a probationary basis — an option
available only to those in the MSc program — if the student has an average less
than 78%, but has the full support of the proposed supervisor and the Associate
Director of Research and Graduate Studies in the School of Pharmacy, as well
as meets all other admission criteria. The student will be evaluated within the first
year of the program and if satisfactory performance in both course work and
research are demonstrated the Advisory Committee will recommend upgrading to
the regular MSc program. If performance is deemed unsatisfactory after the first
year and the potential for further improvement unlikely, the student must
withdraw from the MSc program.
Page 6 of 16
School of Pharmacy
Msc Program
May 2010
Admission of Students from Outside Canada or US
International students whose undergraduate degree was not obtained from a
recognized Canadian or American university will be admitted first into the MSc
program and subsequently transferred to the PhD program within 12 to 18
months, based on satisfactory performance as evaluated by the student’s
Advisory Committee. Under exceptional circumstances or special international
co-operative initiatives, students may be admitted into the PhD program after a
four-year BSc degree (or equivalent) or admitted into the PhD program in which
part of the research or course work may be carried out at an approved
international location, specifically at the co-operating institution under cosupervision by faculty members from both institutions.
International applicants must apply to Citizenship and Immigration Canada, in
their home country, for a Study Permit. Admitted students will be instructed to not
leave for Canada until they have received a Letter of Acceptance issued by the
UW Graduate Studies Office and a Study Permit (IMM 1442) valid for study at
UW, issued by Citizenship and Canada Immigration. These two documents are
required for international applicants to enrol at UW. Applicants will be directed to
consult the appropriate Citizenship and Immigration Canada office for
instructions to apply for a Study Permit.
An official academic transcript from each post-secondary institution must be
submitted with the application for admission. Transcripts must show all courses,
marks and the awarding of degrees. A transcript is considered official only if it is
received in a signed and sealed university envelope (signed on the flap by the
official in the university office issuing the transcript). A certified English translation
must also be included if the official transcripts are written in a language other
than English. Transcripts will be verified by UW for authenticity.
The School of Pharmacy will adopt the international admission guidelines, as
stipulated
by
University
of
Waterloo
Graduate
Studies
(see
http://www.grad.uwaterloo.ca/students/prospective/International/intl_adm_guide.
asp). For international students requiring proof of English proficiency the
minimums required by UW will be used (see English Language Requirements).
If the undergraduate degree was not obtained from a recognized Canadian or
American university, the applicant must write and achieve scores at the 50th
percentile ranking or better on the Graduate Record Examination (GRE) General
Test.
English Language Requirements
The School of Pharmacy will adopt the minimum English language proficiency
requirements of the University of Waterloo.
Applicants who have not completed three or more years of post-secondary work
at a Canadian institution or at an institution at which English was the primary
language of instruction, or have not been employed for a similar period of time in
a position in which English was the primary language of business will be required
Page 7 of 16
School of Pharmacy
Msc Program
May 2010
to provide certification of English language proficiency through one of the
accepted
examinations
below
(see
http://gradcalendar.uwaterloo.ca/
default.aspx?pageID=8945).
Accepted Examinations
Required Score
Test of English as a Foreign
Language (TOEFL) plus Test of
Written English (TWE) or Computerbased TOEFL plus Essay or Internetbased TOEFL (offered through the
Educational Testing Service,
Princeton, NJ, USA)
550 minimum overall score with a minimum of
50 in each section, plus 4.0 minimum for the
TWE; or Computer-based minimum overall
score of 213, plus 4.0 minimum for the Essay;
or Internet-based minimum overall score of 90,
plus 24 minimum in Speaking and Writing
sections.
Michigan English Language
Assessment Battery (MELAB)
85 minimum overall score; minimum of 80 in
each section
International English Language
Testing System (IELTS)
6.5 minimum overall score; minimum 5.5 in
each section
Canadian Academic English
Language Assessment (CAEL)
70 minimum overall score; minimum 60 in each
section
Canadian Test of English for Scholars
and Trainees (CanTEST)
4.5 minimum overall score; minimum 4.0 in
each section
2.2.3. Degree Requirements
Minimum Requirements for the MSc Degree
The minimum requirements for the MSc in Pharmacy are satisfied when
candidates have successfully completed a minimum of three one-term (0.5 unit
weight) courses accepted for graduate credit by the School of Pharmacy, as well
as Pharm 691 (MSc Seminar, 0.5 unit weight), passed the MSc Thesis Proposal
Defence, achieved all MSc Program Milestones and prepared and defended a
thesis embodying the results of their research on a topic approved by their
supervisor and Advisory Committee.
MSc candidates must also enrol in Pharm 6xx (MSc Thesis). Among the three
courses taken, one 400-level course may be accepted toward this requirement if
approved by the supervisor and Advisory Committee. The main criterion for
acceptance will be based on gaining knowledge in an area that is outside the
background of the student but will benefit his/her research program.
A minimum of 60% must be obtained in any graduate course taken by an MSc
student to be granted pass standing, and the candidate must obtain an average
of at least 70% in the courses presented in fulfillment of the MSc degree.
On the recommendation of the Associate Director of Research and Graduate
Studies, School of Pharmacy, and the approval of the Associate Dean of
Graduate Studies, Faculty of Science, an MSc candidate may repeat a course for
higher standing or take an alternate course for credit. If the Associate Director of
Research and Graduate Studies does not make such a recommendation, or if the
Associate Dean of Graduate Studies does not approve the recommendation, the
MSc student will be required to withdraw from the program. A student who
Page 8 of 16
School of Pharmacy
Msc Program
May 2010
obtains a grade of less than 60% in more than one course will normally be
required to withdraw.
The requirements for the MSc degree must be completed within the periods
stipulated by the Senate of the University, normally 6 terms (2 years) of study.
Below is a summary of the required number of courses, grade minimums for
graduate studies in Pharmacy, and degree completion periods —
MSc Program
Three one-term (0.5 unit weight) graduate courses
Pharm 691 (MSc Seminar, 0.5 unit weight)
All graduate courses with a final mark 60% or greater
Overall cumulative average 70% or greater
Completed by six terms (two years)
2.2.4. Program of Studies
The student and his or her supervisor will normally meet before the first meeting
of the student’s Advisory Committee to discuss which graduate courses the
student will enrol in, including the compulsory Graduate Seminar (either Pharm
691). These courses will become part of the student’s individualized program of
studies. The program of studies can be prepared before the first meeting of the
student’s Advisory Committee, but it is formalized at that meeting.
The program of studies will include the following:

Establishing the members of the student’s Advisory Committee

Establishing course requirements, including Pharm 691 (MSc Seminar), in
consultation with the supervisor and Advisory Committee, ensuring that
appropriate courses are chosen and that the minimum number of credit units
are met.

Determining if any additional non-credit courses, such as animal care and
use, laboratory safety, radiation safety and biosafety courses or workshops,
must be taken.

Determining whether ethics approval is required for the proposed research
and when it will be granted. As per UW policy, ethics approval is needed for
all research involving humans or animals.

Approving transfer credits for courses from another university, if applicable;
original transcripts for these courses must be on file with UW Graduate
Studies and a copy placed in the student’s file in the School of Pharmacy.
The program of studies is approved by the School of Pharmacy’s Graduate Chair
and submitted to the Associate Director, Research and Graduate Studies. A copy
will be given to the student, which will form a contract between UW and the
Page 9 of 16
School of Pharmacy
Msc Program
May 2010
student, noting the requirement to successfully complete courses, meet other
requirements, pass examinations and defend a thesis.
Changes in course requirements, supervisor or Advisory Committee members, or
a significant change in the student’s research area, will require that a new
program of studies be prepared, approved and submitted.
2.2.5. Student Advisory Committee
An Advisory Committee is established as soon as possible after a candidate’s
registration. The supervisor determines the members of the Advisory Committee,
in consultation with the student and the Graduate Chair. Subsequent changes to
the Advisory Committee are made by the Committee itself.
An MSc Advisory Committee must include at least three members, in addition to
the Advisory Committee Chair an comprised of the following individuals:
Advisory Committee Chair – This may be the Pharmacy Graduate Chair or his
or her designate. In most cases, the designate will be an Advisory Committee
member who is otherwise required to be present to facilitate efficiency.
Supervisor – A faculty member within the School of Pharmacy.
Co-supervisor – If applicable, persons who are not faculty members in the
School of Pharmacy or who are not Adjunct Professors may be granted
permission to be a co-supervisor by the Associate Director, Research and
Graduate Studies. Co-supervisors count as one member in the Advisory
Committee and share one vote in decision-making at the oral defence.
Additional Members – A minimum of two for an MSc candidate. They must be
faculty members or clinical adjunct faculty of the School of Pharmacy or be
granted permission by the Dean of Science to be a member.
Associate Director of Research and Graduate Studies – The Associate
Director of Research and Graduate is an ex officio member of the Advisory
Committee and normally attends meetings only under exceptional or extenuating
circumstances.
2.2.6. Annual Committee Meetings and Progress Reports
The progress of all MSc students will be monitored regularly. A student may be
required to withdraw from the graduate program if progress has not been
satisfactory, as evidenced by substandard course work, a mediocre or untenable
research proposal, lack of research activity, poor comprehensive exam
performance or other such deficiencies that have not been adequately remedied.
All MSc students will meet with their Advisory Committee shortly after enrolment
to select courses necessary to meet program and personal requirements. After
Page 10 of 16
School of Pharmacy
Msc Program
May 2010
this initial meeting, MSc students will meet with their Advisory Committee within
the first year of their program and present a research proposal. The Advisory
Committee will assess the proposal for scientific merit and feasibility, and set
program milestones.
Students will continue to meet with their Advisory Committee annually, and
submit a progress report they prepare for its members at least one week before
the annual meeting, to report on their research progress and objectives thus far
attained. The Committee will assess the student’s progress and suggest
corrective measures, if necessary, and may also suggest new or alternate
avenues to advance the student’s research. In certain years the annual meeting
with the Advisory Committee will coincide with other major programmatic
milestones, such as the Proposal Defence, or the “Permission to Write” meeting,
as outlined in Table 1.
In the last year of the program, the Annual Meeting includes both an evaluation
of progress to date, as well as a determination of whether the student is ready to
prepare a thesis. The purpose of this “Permission to Write” meeting is to evaluate
whether a student is ready to defend his or her thesis. The student must
demonstrate that through the graduate courses completed, progress reports
prepared, exams passed and data thus far collected and preliminarily analyzed,
that not only does he or she have sufficient knowledge and understanding of the
research topic, but also sufficient data to prepare a defendable thesis.
Monitoring the academic progress of graduate students is the primary
responsibility of the supervisor, co-supervisor and Advisory Committee. Chairs of
Advisory Committees should bring any problems related to academic progress to
the attention of the Associate Dean of Graduate Studies, Faculty of Science.
The Graduate Chair will review the progress of all graduate students at least
once a year, based on any or all of the following: academic transcripts, progress
reports for annual Advisory Committee meetings and student CVs. All graduate
students will be expected to submit an updated CV each year when requested by
the Graduate Office.
The Graduate Chair, in consultation with the research supervisor(s), will inform
students in writing of unsatisfactory progress.
2.2.7. MSc Thesis Preparation and Submission Procedures
All students are expected to consult the University of Waterloo Thesis
Regulations website for detailed guidelines: http://www.grad.uwaterloo.ca/
students/current/thesis_regulations.asp
Preparation of MSc Thesis for Defence
The student submits a draft thesis to his or her supervisor/co-supervisor for
review. The supervisor/co-supervisor will provide comments and the student will
prepare revisions as required. When a satisfactory version of the thesis is
Page 11 of 16
School of Pharmacy
Msc Program
May 2010
completed, the student provides the thesis to the Advisory Committee, along with
a memo from the Graduate Chair, which requests that comments be provided to
the student within two weeks. The student prepares the final version of the thesis
ready to be submitted to the External Examiner (for MSc candidates, the External
is an Examiner outside the School of Pharmacy but within University of
Waterloo). The Advisory Committee meets only if major concerns are raised.
The supervisor in consultation with the Advisory Committee identifies an External
Examiner and determines a potential date for the defence.
The Graduate Chair notifies the Associate Dean of Research and Graduate
Studies of the defence date and the name of the External Examiner at least four
weeks before the scheduled thesis defence date. The Graduate Chair maintains
a record of approved External Examiners, CVs and correspondence.
The student provides a final copy of the thesis to Advisory Committee members
and one copy to the Graduate Secretary at least three weeks before the defence.
The Graduate Secretary ensures that the thesis copy is immediately delivered to
the External Examiner. The student must not have direct contact with the
External Examiner before the defence.
Page 12 of 16
School of Pharmacy
Msc Program
May 2010
TABLE 1: Suggested timelines and milestones to complete the Master’s degree in Pharmacy
Master’s degree in Pharmacy — maximum of 6 terms (2 years)
 Select supervisor and research topic
 Select Advisory Committee
 Determine individual program of studies, including graduate courses necessary to fulfill
Year I
requirements (courses selected in consultation with supervisor and Advisory Committee)
Terms 1, 2 and 3  Begin course work; course work can extend into term three, but should be completed before end of
term 4
 Begin research
 Annual committee meeting #1: MSc Research Proposal Defence (by end of term 3)
 Continue with research
Year II
Terms 4, 5 and 6
 Annual committee meeting #2: Prepare progress report and hold Advisory Committee
meeting for permission to write thesis (usually in term 4 or 5)
 Complete any outstanding research
 Write and defend thesis
Page 13 of 16
School of Pharmacy
Msc Program
May 2010
2.2.8. Thesis Defence
Master’s Thesis
The MSc Examination Committee will consist of the Graduate Chair or his or
designate, the Supervisor, the Advisory Committee members and the External
Examiner. The Examination Committee will read the thesis, attend the defence,
examine the student through a series of questions and suggest changes and
revisions as necessary, then determine if the thesis and its defence are
satisfactory. The thesis defence consists of a public presentation by the student
(usually 20 minutes long) of the essential results and conclusions of the thesis,
followed by an extensive question-and-answer period. In the first part, the
Examination Committee members, starting with the External Examiner, will ask
two rounds of questions followed by questions from the audience. Thereafter, the
student and the audience will be asked to leave and the Examiners will deliberate
to make a decision on the acceptability of the thesis and the defence.
One of the following recommendations will be made:
1. Accepted
2. Accepted conditionally (may require further consultation with the Examiners)
3. Decision deferred (thesis must be revised and resubmitted for reexamination)
4. Rejected
After the decision by the Examination Committee, the student will be called back
for detailed feedback on the performance and any requirements for revisions.
After the MSc candidate has made corrections to the thesis, he or she must
verify with the supervisor and one of the readers that the corrections have
substantively addressed the Examiners’ concerns. The Examiners may also set a
deadline for completion of revisions.
When complete, the final copy must be submitted to the Graduate Studies Office
via the electronic thesis website (http://www.ist.uwaterloo.ca/ew/ethesis/
ethesis.html) for review before binding. The Graduate Studies Office will then
direct the student on binding procedures.
Page 14 of 16
School of Pharmacy
3.1.
Msc Program
May 2010
Total graduate courses listed and level
School of Pharmacy graduate courses and the faculty who will be primarily
responsible for teaching them in are listed in Table 2. The frequency of offering
courses will be adjusted by demand. A minimum enrolment number will be needed to
offer courses in each year. If enrolment is lower than the limit set for the course, the
course may be offered the following year. Selected courses will only be offered every
second year.
The following graduate courses are proposed for introduction for Sept 2010 and for January 2011:
Pharm 6XX
Selected Topics in Medicinal Chemistry (Sept 2010)
Pharm 6XX
Gene Therapy (Sept 2010)
Pharm 6XX
Physical Chemistry and Applications of Surfactants (Sept 2010)
Pharm 6XX
Pharmaceutical Grant Writing (Sept 2010)
Pharm 6XX
Advanced Pharmaceutical Analysis (Jan 2010)
Pharm 6XX
Neuroscience in the 21st Century (Jan 2011)
Pharm 6XX
Seminar (Sept 2010)
All course syllabi are attached.
Page 15 of 16
School of Pharmacy
Msc Program
May 2010
TABLE 2. Courses to be developed within the Graduate Program in Pharmacy
Course1
Pharm 691
Course Title (weight)
Faculty member(s) responsible
MSc Seminar (0.5); mandatory enrolment for MSc
students
Supervisor, Advisory Committee members
Pharm 6xx MSc Thesis; mandatory enrolment for MSc students Supervisor, Advisory Committee members
Pharm 6xx Grant writing (0.5)
Edginton, Foldvari, Joseph, Nekkar, Slavcev, Wettig
Pharm 6XX Physical Chemistry and Applications of Surfactants (0.5) Wettig
Pharm 6XX Neuroscience in the 21st century
Beazely
Pharm 6XX Gene therapy (0.5)2
Foldvari, Joseph, Slavcev, Wettig
Pharm 6XX Selected topics in medicinal chemistry (0.5)
Nekkar
Pharm 6XX Advanced pharmaceutical analysis (0.5)
Nekkar
1.
2.
Course numbers have not yet been assigned
It is expected that this course will be taught in modules by faculty members with different areas of expertise in gene therapy method
Page 16 of 16
OCGS APPRAISAL BRIEF - [Pharmacy]
Page 17 of 16
page 17